Kepos Capital LP Eli Lilly & CO Transaction History

Kepos Capital LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$119.05 - $147.35 $354,769 - $439,103	-2,980 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $318,621 - $394,641	2,980 New	2,980 $392,000
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $2.4 Million - $2.61 Million	-22,454 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $2.82 Million - $3.29 Million	-25,454 Reduced 53.13%	22,454 $2.49 Million
Q1 2019 May 13, 2019	BUY	$111.31 - $131.02 $5.33 Million - $6.28 Million	47,908 New	47,908 $6.22 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $6.59 Million - $8.24 Million	-76,768 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $5.81 Million - $6.67 Million	76,768 New	76,768 $6.55 Million
Q4 2017 Feb 12, 2018	SELL	$81.94 - $87.89 $930,510 - $998,078	-11,356 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $875,206 - $971,392	11,356	11,356 $971,000

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.